During the past decade, Beijing Jingmei Group General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Jingmei Group General Hospital" #1 sponsor was "Peking University First Hospital" with 2 trials, followed by "Chinese Academy of Medical Sciences, Fuwai Hospital" with 1 trials sponsored, "Ji Xunming,MD,PhD" with 1 trials sponsored, "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials sponsored and "Stryker Neurovascular" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Jingmei Group General Hospital" #1 collaborator was "Beijing Luhe Hospital" with 3 trials as a collaborator, "People's Hospital of Beijing Daxing District" with 3 trials as a collaborator, "Aerospace 731 Hospital" with 2 trials as a collaborator, "Beijing Jingmei Group General Hospital" with 2 trials as a collaborator and "Beijing Jishuitan Hospital" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Jingmei Group General Hospital" are "Air Pollution" (1 trials), "Anal Fistula" (1 trials), "Anal Function" (1 trials), "COPD" (1 trials) and "COPD Exacerbation" (1 trials). Many other conditions were trialed in "Beijing Jingmei Group General Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Jingmei Group General Hospital" are "Drug" (3 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Budesonide/formoterol" (1 trials), "Doctormate® (200mmHg)" (1 trials), "Doctormate® (60mmHg)" (1 trials), "Dual anti-platelet therapy" (1 trials) and "Health Services for Systematic Hypertension Management" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Jingmei Group General Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Jingmei Group General Hospital". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Beijing Jingmei Group General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Jingmei Group General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".